Community Report
2020

Innovating for Cancer Treatment and Prevention

LifeLabs is partnering with Bayer to offer cancer patients FastTRK, a new test for targeting a rare form of cancer caused by a specific genetic mutation. The test can help determine whether a customer is eligible for a targeted treatment option.

As a key partner in our core services, we continue to work with our government partners and local health agencies and authorities to support testing and preventive health programs. LifeLabs teams worked with the BC Cancer Agency and the Provincial Health Services Authority (PHSA) to implement a new platform for Fecal Immunochemical Testing, or FIT, a crucial part of the early screening process for colon cancer.

 

There is a lot more to discover!